Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants

NCT05144035 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT05144035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05144035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 6, 2022
Completion date
June 30, 2026
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive developmental disorder, growth hormone treatment, small for gestational age infant